4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001793412-26-000002
CHIEF FINANCIAL OFFICER acquired 359,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Alam Kamran CHIEF FINANCIAL OFFICER | 2026-01-12 | Grant or award | +359,000 | 1,546,603 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Alam Kamran CHIEF FINANCIAL OFFICER | 2026-01-12 | Grant or award · Employee Stock Option (right to buy) | +231,000 | 231,000 | D: show line 2 in the form |
Loading xslF345X05/form4-01142026_040105.xml…